262 related articles for article (PubMed ID: 32083547)
21. Anti-SSA Ro52/Ro60 antibody testing by immunodot could help the diagnosis of Sjogren's syndrome in the absence of anti-SSA/SSB antibodies by ELISA.
Mekinian A; Nicaise-Roland P; Chollet-Martin S; Fain O; Crestani B
Rheumatology (Oxford); 2013 Dec; 52(12):2223-8. PubMed ID: 24026249
[TBL] [Abstract][Full Text] [Related]
22. Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome.
Ohlsson M; Jonsson R; Brokstad KA
Scand J Immunol; 2002 Nov; 56(5):456-69. PubMed ID: 12410795
[TBL] [Abstract][Full Text] [Related]
23. New coupled-particle light-scattering assay for detection of Ro/SSA (52 and 60 kilodaltons) and La/SSB autoantibodies in connective tissue diseases.
Bizzaro N; Bonelli F; Tonutti E; Tozzoli R; Villalta D
Clin Diagn Lab Immunol; 2001 Sep; 8(5):922-5. PubMed ID: 11527804
[TBL] [Abstract][Full Text] [Related]
24. Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome.
Burbelo PD; Leahy HP; Issa AT; Groot S; Baraniuk JN; Nikolov NP; Illei GG; Iadarola MJ
Autoimmunity; 2009 Sep; 42(6):515-24. PubMed ID: 19657778
[TBL] [Abstract][Full Text] [Related]
25. Immune responses to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies.
Deshmukh US; Lewis JE; Gaskin F; Kannapell CC; Waters ST; Lou YH; Tung KS; Fu SM
J Exp Med; 1999 Feb; 189(3):531-40. PubMed ID: 9927515
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren's syndrome.
Gál I; Lakos G; Zeher M
Autoimmunity; 2000 Sep; 32(2):89-92. PubMed ID: 11078154
[TBL] [Abstract][Full Text] [Related]
27. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
Front Immunol; 2018; 9():1200. PubMed ID: 29922285
[TBL] [Abstract][Full Text] [Related]
29. The prevalence and the clinical relevance of anti-Ro52 in Korean patients with primary Sjögren's syndrome.
Song JS; Do JH; Lee SW
Rheumatol Int; 2012 Feb; 32(2):491-5. PubMed ID: 21246358
[TBL] [Abstract][Full Text] [Related]
30. Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection.
Menéndez A; Gómez J; Escanlar E; Caminal-Montero L; Mozo L
Autoimmunity; 2013 Feb; 46(1):32-9. PubMed ID: 23039326
[TBL] [Abstract][Full Text] [Related]
31. Spreading of the immune response from 52 kDaRo and 60 kDaRo to calreticulin in experimental autoimmunity.
Kinoshita G; Keech CL; Sontheimer RD; Purcell A; McCluskey J; Gordon TP
Lupus; 1998; 7(1):7-11. PubMed ID: 9493142
[TBL] [Abstract][Full Text] [Related]
32. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease.
Peene I; Meheus L; De Keyser S; Humbel R; Veys EM; De Keyser F
Ann Rheum Dis; 2002 Oct; 61(10):929-33. PubMed ID: 12228166
[TBL] [Abstract][Full Text] [Related]
33. Sicca syndrome in the same family - the importance of anti-Ro60, anti-Ro52 and anti-La antibody profiling in Sjögren's syndrome.
Koszarny A; Majdan M
Reumatologia; 2021; 59(4):260-264. PubMed ID: 34538957
[TBL] [Abstract][Full Text] [Related]
34. IgV peptide mapping of native Ro60 autoantibody proteomes in primary Sjögren's syndrome reveals molecular markers of Ro/La diversification.
Wang JJ; Al Kindi MA; Colella AD; Dykes L; Jackson MW; Chataway TK; Reed JH; Gordon TP
Clin Immunol; 2016 Dec; 173():57-63. PubMed ID: 27609500
[TBL] [Abstract][Full Text] [Related]
35. Association of Combined Anti-Ro52/TRIM21 and Anti-Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation.
Bettacchioli E; Saraux A; Tison A; Cornec D; Dueymes M; Foulquier N; Hillion S; Roguedas-Contios AM; Benyoussef AA; Alarcon-Riquelme ME; Pers JO; Devauchelle-Pensec V;
Arthritis Rheumatol; 2024 May; 76(5):751-762. PubMed ID: 38130019
[TBL] [Abstract][Full Text] [Related]
36. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.
Bentow C; Swart A; Wu J; Seaman A; Manfredi M; Infantino M; Benucci M; Lakos G; Mahler M
Clin Chim Acta; 2013 Sep; 424():141-7. PubMed ID: 23727029
[TBL] [Abstract][Full Text] [Related]
37. The 52 000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures.
Rhodes DA; Ihrke G; Reinicke AT; Malcherek G; Towey M; Isenberg DA; Trowsdale J
Immunology; 2002 Jun; 106(2):246-56. PubMed ID: 12047754
[TBL] [Abstract][Full Text] [Related]
38. Retrospective analysis of the clinical significance of Ro52/TRIM21 antibody and specific antinuclear antibody patterns by indirect immunofluorescence.
Liu K; Liao Y; Li P; Shi J
J Pak Med Assoc; 2024 Feb; 74(2):236-242. PubMed ID: 38419219
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of tests for SS-A/Ro, Ro52 and Ro60 in predicting congenital heart block].
Miyano A; Nakayama M; Waguri M; Nakanishi I
Rinsho Byori; 2014 Apr; 62(4):324-31. PubMed ID: 25022061
[TBL] [Abstract][Full Text] [Related]
40. Recurrent pregnancy loss and autoantibody profile in autoimmune diseases.
Mavragani CP; Ioannidis JP; Tzioufas AG; Hantoumi IE; Moutsopoulos HM
Rheumatology (Oxford); 1999 Dec; 38(12):1228-33. PubMed ID: 10587550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
